The role of glatiramer acetate in the early treatment of multiple sclerosis

Figures & data

Table 1 Side effect profile of glatiramer acetate and interferon-beta

Glatiramer acetate	Interferon-beta
Injection-site reactions erythema, itching, swelling, pain	Injection-site reaction erythema, itching, swelling, pain
Lipoatrophy and SQ nodules	Injection-site necrosis
Immediate post-injection reaction	Flu-like symptoms Hepatotoxicity Hematologic toxicity Increased spasticity Worsening of depression Neutralizing antibodies

Modified with permission from Perumal J, Filippi M, Ford C, et al. Glatiramer acetate therapy for multiple sclerosis: a review. Expert Opin Drug Metab Toxicol. 2006;2:1019–1029.³⁶ Copyright © 2006 Taylor & Francis.

PerumalJFilippiMFordCGlatiramer acetate therapy for multiple sclerosis: a reviewExpert Opin Drug Metab Toxicol200621019102917125414

 PubMed Web of Science ®Google Scholar